
We compared the effects of zzso and zzso zzso preparations in adult patients with zzso cancer pain and report zzso approaches to pain zzso The study consisted of a zzso zzso crossover trial preceded by a zzso zzso all zzso were conducted under zzso zzso To evaluate pain intensity, a visual analogue scale zzso and the Present zzso zzso scale of the McGill zzso zzso were zzso Additional zzso solution for breakthrough pain was used as an outcome zzso zzso was evaluated nine times daily, which permitted correlation of pain scores with the zzso patterns of the test zzso Side effects were rated once daily, using a scale from 0 to zzso To assess the relative importance of side effects, a toxicity index was designed based on both the intensity and duration of each side zzso The overall zzso pain scores during treatment with zzso and zzso zzso were zzso zzso zzso zzso and zzso zzso zzso zzso zzso Use of supplemental zzso solution for breakthrough pain expressed as the percentage of the daily dose of the test drug was zzso for the zzso drug and zzso for the zzso zzso zzso in pain scores, side effects, and supplemental zzso requirement between the two groups were not zzso We discuss zzso issues in zzso clinical trials of zzso in particular the zzso of zzso zzso as an outcome measure and problems related to the zzso zzso 

